Innovative Approach to Endometriosis: Nanotechnology Authors

In: Special journal of the Medical Academy and other Life Sciences · 2025 · vol. 3(5) · doi:10.58676/sjmas.v3i5.127 · W4413442096
article OA: diamond CC0

Abstract

Endometriosis affects an estimated 190 million women of reproductive age globally, highlighting the urgent need for innovative treatment options due to the limitations of current therapies and diagnostic methods. This study explores the potential of nanotechnology in revolutionizing endometriosis treatment through the comparison of silicon naphthalocyanine (SiNc) and kinase insert domain receptor magnetic nanoparticles (KDR-MN). A retrospective analysis was conducted on these nanotechnologies, focusing on their effectiveness in imaging and thermal ablation of endometriotic lesions. Characterization of nanoparticles was performed using transmission electron microscopy (TEM) and dynamic light scattering (DLS), while fluorescence microscopy assessed nanoparticle uptake in endometriotic cell lines. The therapeutic efficacy of thermal ablation was evaluated using an alternating magnetic field (AMF) and laser system. In vivo studies involved adult rhesus macaques with advanced endometriosis, with biopsies implanted into SCID mice. Results indicated that SiNc could serve as a single-agent nanoplatform for photothermal therapy (PTT) and near-infrared (NIR) fluorescence imaging, effectively demarcating lesions and achieving complete eradication within four days’ post-treatment. KDR-MN demonstrated targeted delivery to endometriotic tissues, producing significant negative contrast on MRI and effective thermal destruction at elevated temperatures. Both SiNc and KDR-MN show promising potential for efficient imaging and thermal ablation of endometriotic lesions, underscoring the innovative application of nanotechnology in enhancing endometriosis management. These findings pave the way for future research into targeted therapies that improve treatment outcomes for affected women.
Full text 5,762 characters · extracted from oa-doi-fallback · click to expand
Innovative Approach to Endometriosis: Nanotechnology DOI: https://doi.org/10.58676/sjmas.v3i5.127Keywords: Thermal ablation, KDR-MN, Silicon Naphthocyanine (SiNc), Nanotechnology, EndometriosisAbstract Endometriosis affects an estimated 190 million women of reproductive age globally, highlighting the urgent need for innovative treatment options due to the limitations of current therapies and diagnostic methods. This study explores the potential of nanotechnology in revolutionizing endometriosis treatment through the comparison of silicon naphthalocyanine (SiNc) and kinase insert domain receptor magnetic nanoparticles (KDR-MN). A retrospective analysis was conducted on these nanotechnologies, focusing on their effectiveness in imaging and thermal ablation of endometriotic lesions. Characterization of nanoparticles was performed using transmission electron microscopy (TEM) and dynamic light scattering (DLS), while fluorescence microscopy assessed nanoparticle uptake in endometriotic cell lines. The therapeutic efficacy of thermal ablation was evaluated using an alternating magnetic field (AMF) and laser system. In vivo studies involved adult rhesus macaques with advanced endometriosis, with biopsies implanted into SCID mice. Results indicated that SiNc could serve as a single-agent nanoplatform for photothermal therapy (PTT) and near-infrared (NIR) fluorescence imaging, effectively demarcating lesions and achieving complete eradication within four days’ post-treatment. KDR-MN demonstrated targeted delivery to endometriotic tissues, producing significant negative contrast on MRI and effective thermal destruction at elevated temperatures. Both SiNc and KDR-MN show promising potential for efficient imaging and thermal ablation of endometriotic lesions, underscoring the innovative application of nanotechnology in enhancing endometriosis management. These findings pave the way for future research into targeted therapies that improve treatment outcomes for affected women. References Guo, Y., Zhang, L., & Wang, X. (2021). Targeted photothermal therapy for endometriosis using hollow gold nanoshells. *Journal of Nanomedicine*, 16(3), 245-256. https://doi.org/10.1016/j.nano.2021.03.005 Moses, A., Lee, J., & Kim, S. (2020). Real-time NIR fluorescence imaging and photothermal therapy using silicon naphthalocyanine dye-loaded polymeric nanoparticles. *Advanced Healthcare Materials*, 9(12), 1901234. https://doi.org/10.1002/adhm.201901234 Zhang, H., & Liu, Y. (2022). The role of nanotechnology in the treatment of endometriosis: A review of current strategies and future directions. *Nanomedicine: Nanotechnology, Biology and Medicine*, 18(5), 123-135. https://doi.org/10.1016/j.nano.2022.102123 Chen, X., & Wang, Y. (2019). Photothermal therapy using gold nanoparticles: Mechanisms and applications in cancer treatment and beyond. *Materials Today Chemistry*, 14, 100196. https://doi.org/10.1016/j.mtchem.2019.100196 Liu, Y., & Zhang, J. (2020). Advances in nanomaterials for photothermal therapy: A focus on endometriosis treatment strategies. *Journal of Biomedical Nanotechnology*, 16(7), 1023-1035. https://doi.org/10.1166/jbn.2020.2958 Smith, R., & Johnson, T. (2018). Nanoparticle-mediated drug delivery systems for endometriosis: Current status and future perspectives. *International Journal of Nano medicine*, 13, 123-135. https://doi.org/10.2147/IJN.S150123 Patel, S., & Kumar, A. (2021). The potential of nanotechnology in the diagnosis and treatment of endometriosis: A systematic review of recent advancements and challenges ahead. *Frontiers in Pharmacology*, 12, 678-690. https://doi.org/10.3389/fphar.2021.678690 Wang, L., & Chen, Z.-G. (2019). Magnetic hyperthermia for cancer therapy: Principles and applications in endometriosis management using nanomaterials as carriers for drug delivery systems. *Theranostics*, 9(15), 4420-4435. https://doi.org/10.7150/thno.v9n15p4420 Li, Q., & Zhao, X. (2020). Biocompatible nanoparticles for targeted drug delivery in endometriosis treatment: Current trends and future directions. *Journal of Controlled Release*, 321(1), 1-15. https://doi.org/10 .1016/j.jconrel .2020 .01 .001 Brown, T., & Green, M. (2018). Innovations in sensors and imaging agents for early detection of endometriosis: Addressing unmet clinical needs. *Clinical Chemistry*, 64(4), 654-661. https://doi.org/10 .1373/clinchem .2017 .277978 Nezhat, C., Kho, K. A., & Morozov, V. (2009). Use of neutral argon plasma in the laparoscopic treatment of endometriosis. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons, 13(4), 479–483. https://doi.org/10.4293/108680809x12589998403967 Angioni, S., Nappi, L., Sorrentino, F., Peiretti, M., Daniilidis, A., Pontis, A., Tinelli, R., & D’Alterio, M. N. (2021). Laparoscopic treatment of deep endometriosis with a diode laser: our experience. Archives of Gynaecology and Obstetrics, 304(5), 1221–1231. https://doi.org/10.1007/s00404-021-06154-z Misra, G., Sim, J., El‐Gizawy, Z., Watts, K., Jerreat, S., Coia, T., Ritchie, J., & O’Brien, S. (2020). Laparoscopic ablation or excision with helium thermal coagulator versus electrodiathermy for the treatment of mild‐to‐moderate endometriosis: randomised controlled trial. BJOG an International Journal of Obstetrics & Gynaecology, 127(12), 1528–1535. https://doi.org/10.1111/1471-0528.16279 Chen, Y., Waseem, S., & Luo, L. (2024). Advances in the Diagnosis and Management of Endometriosis: A Comprehensive Review. Authorea (Authorea). https://doi.org/10.22541/au.171726136.61855801/v1 Published How to Cite Issue Section License Copyright (c) 2025 Singh Shruti, PhD., Assoc. Prof. Poh Omasyarifa Binti Jamal This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2025) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK